Sterol regulatory element-binding protein (SREBP)-1: gene regulatory target for insulin resistance?

Bibliography

• BRIGGS MR, YOKOYAMA C, WANG X, BROWN MS, GOLDSTEIN JL: Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. Biol. Chem. (1993) 268:14490–14496.
   Google Scholar
• HUA X, YOKOYAMA C, VVU J et al.: SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc. Natl. Acad. Sci. USA (1993) 90:11603–11607.
   PubMed Web of Science ®Google Scholar
• WANG X, BRIGGS MR, HUA X, YOKOYAMA C, GOLDSTEIN JL, BROWN MS: Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization. Biol. Chem. (1993) 268:14497–14504.
   Google Scholar
• YOKOYAMA C, WANG X, BRIGGS MR et al.: SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell (1993) 75:187–197.
   PubMed Web of Science ®Google Scholar
• TONTONOZ P, KIM JB, GRAVES RA, SPIEGELMAN BM: ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Mol. Cell. Biol. (1993) 13:4753–4759.
   PubMed Web of Science ®Google Scholar
• ••This study describes for the first time therole of ADD 1 or SREBP1r in the differentiation of fat cells, thereby providing a direct possible link between SREBP1 and body fat.
   Google Scholar
• HUA X, WU J, GOLDSTEIN JL, BROWN MS, HOBBS HH: Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Grammies (1995) 25:667–673.
   PubMed Web of Science ®Google Scholar
• SHIMOMURA I, SHIMANO H, HORTON JD et al.: Differential expression of exons la and lc in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. Clin. Invest. (1997) 99:838–845.
   Google Scholar
• HUA X, SAKAI J, HO YK, GOLDSTEIN JL, BROWN MS: Hairpin orientation of sterol regulatory element-binding protein-2 in cell membranes as determined by protease protection. J. Biol. Chem. (1995) 270:29422–29427.
   PubMedGoogle Scholar
• SAKAI J, NOHTURFFT A, GOLDSTEIN JL, BROWN MS: Cleavage of sterol regulatory element-binding proteins (SREBPs) at site-1 requires interaction with SREBP cleavage-activating protein. Evidence from in vivo competition studies. Biol. Chem. (1998) 273:5785–5793.
   PubMed Web of Science ®Google Scholar
• RAWSON RB, ZELENSKI NG, NIJHAWAN D et al.: Complementation cloning of 52P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol. Cell (1997) 1:47–57.
   PubMed Web of Science ®Google Scholar
• DUNCAN EA, DAVE UP, SAKAI J, GOLDSTEIN JL, BROWN MS: Second-site cleavage in sterol regulatory element-binding protein occurs at transmembrane junction as determined by cysteine panning. J. Biol. Chem. (1998) 273:17801–17809.
   PubMedGoogle Scholar
• HUA X, NOHTURFFT A, GOLDSTEIN JL, BROWN MS: Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell (1996) 87:415–426.
   PubMed Web of Science ®Google Scholar
• HUA X, SAKAI J, BROWN MS, GOLDSTEIN JL: Regulated cleavage of sterol regulatory element binding proteins requires sequences on both sides of the endoplasmic reticulum membrane. Biol Chem. (1996) 271:10379–10384.
   Google Scholar
• SAKAI J, NOHTURFFT A, CHENG D, HO YK, BROWN MS, GOLDSTEIN JL: Identification of complexes between the COOH-terminal domains of sterol regulatory element-binding proteins (SREBPs) and SREBP cleavage-activating protein. J. Biol. Chem. (1997) 272:20213–20221.
   PubMedGoogle Scholar
• RAWSON RB, DEBOSE-BOYD R, GOLDSTEIN JL, BROWN MS: Failure to cleave sterol regulatory element-binding proteins (SREBPs) causes cholesterol auxotrophy in Chinese hamster ovary cells with genetic absence of SREBP cleavage-activating protein. J. Biol. Chem. (1999) 274:28549–28556.
   PubMed Web of Science ®Google Scholar
• NOHTURFFT A, YABE D, GOLDSTEIN JL, BROWN MS, ESPENSHADE PJ: Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes. Cell (2000) 102:315–323.
   PubMedGoogle Scholar
• ••The role of SCAP in cellular trafficking ofSREBPs is defined.
   Google Scholar
• YANG T, ESPENSHADE PJ, WRIGHT ME et al.: Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell(2002) 110:489–500.
   PubMed Web of Science ®Google Scholar
• ••Insig-1 is characterised by using a very elegantexperimental approach providing first insights into the regulation of nuclear transport.
   Google Scholar
• YABE D, BROWN MS, GOLDSTEIN JL: Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins. Proc. Natl. Acad. Sci. USA (2002) 99:12753–12758.
   PubMed Web of Science ®Google Scholar
• YABE D, KOMURO R, LIANG G, GOLDSTEIN JL, BROWN MS: Liver-specific mRNA for Insig-2 downregulated by insulin: implications for fatty acid synthesis. Proc. Natl. Acad. Sci. USA (2003) 100:3155–3160.
   PubMed Web of Science ®Google Scholar
• DOBROSOTSKAYA IY, GOLDSTEIN JL, BROWN MS, RAWSON RB: Reconstitution of sterol-regulated endoplasmic reticulum-to-Golgi transport of SREBP-2 in insect cells by co-expression of mammalian SCAP and insigs. I Biol. Chem. (2003) 278:35837–35843.
   Google Scholar
• ••These very well-performed reconstitutionanalyses prove the hypothesis about the essential components and their interaction in the sterol-regulated cleavage process.
   Google Scholar
• FORETZ M, PACOT C, DUGAIL I et al:ADD1/SREBP-lc is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell. Biol. (1999) 19:3760–3768.
   PubMed Web of Science ®Google Scholar
• FORETZ M, GUICHARD C, FERRE P, FOUFELLE F: Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc. Natl. Acad. Sci. USA (1999) 96:12737–12742.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO M, OGAWA W, TESHIGAWARA K et al: Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein lc and glucokinase genes in rat hepatocytes. Diabetes (2002) 51: 1672-1680.
   Google Scholar
• MATSUMOTO M, OGAWA W, AKIMOTO K et al.: PKCX in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. Clin. Invest. (2003) 112:935–944.
   Google Scholar
• STREICHER R, KOTZKA J, MULLER-WIELAND D et al.: SREBP-1 mediates activation of the lowdensity lipoprotein receptor promoter byinsulin and insulin-like growth factor-I.Biol. Chem. (1996) 271:7128–7133.
   Google Scholar
• •Provides direct evidence that SREBPs can be integral members of the insulin signalling cascades.
   Google Scholar
• KOTZKA J, MULLER-WIELAND D, KOPONEN A et al: ADD1/SREBP- lc mediates insulin-induced gene expression linked to the MAP kinase pathway. Biochem. Biophys. Res. Commun. (1998) 249:375–379.
   PubMed Web of Science ®Google Scholar
• KOTZKA J, MULLER-WIELAND D, ROTH G et al.: Sterol regulatory element binding proteins SREBP- la and SREBP-2 are linked to the map kinase cascade. Lipid Res. (2000) 41:99–108.
   PubMed Web of Science ®Google Scholar
• ROTH G, KOTZKA J, KREMER L et al.: MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)- la at serine 117 M vitro. J. Biol. Chem. (2000) 275:33302–33307.
   PubMed Web of Science ®Google Scholar
• ••SREBPs can be regulated bypost-translational modification, that is, phosphorylation.
   Google Scholar
• EDWARDS PA, TABOR D, KAST HR, VENKATESWARAN A: Regulation of gene expression by SREBP and SCAP. Biochim. Biophys. Acta (2000) 1529:103–113.
   PubMed Web of Science ®Google Scholar
• DOOLEY KA, BENNETT MK, OSBORNE TF: A critical role for cAMP response element-binding protein (CREB) as a co-activator in sterol-regulated transcription of 3-hydroxy-3-methylglutaryl coenzyme A synthase promoter. J. Biol. Chem. (1999) 274:5285–5291.
   PubMedGoogle Scholar
• MOLDES M, BOIZARD M, LIEPVRE XL, FEVE B, DUGAIL I, PAIRAULT J: Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-lc (ADD 1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes. Biochem. J. (1999) 344:873–880.
   PubMedGoogle Scholar
• LOPEZ D, SHEA-EATON W, SANCHEZ MD, MCLEAN MP: DAX-1 represses the high-density lipoprotein receptor through interaction with positive regulators sterol regulatory element-binding protein- la and steroidogenic factor-1. Endocrinology (2001) 142:5097–5106.
   PubMedGoogle Scholar
• LOPEZ D, SANCHEZ MD, SHEA-EATON W, MCLEAN MP: Estrogen activates the high-density lipoprotein receptor gene via binding to estrogen response elements and interaction with sterol regulatory element binding protein-1A. Endocrinology (2002) 143:2155–2168.
   PubMedGoogle Scholar
• NGO TT, BENNETT MK, BOURGEOIS AL, 10TH JI, OSBORNE TF: A role for cyclic AMP response element-binding protein (CREB) but not the highly similar ATF-2 protein in sterol regulation of the promoter for 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Biol. Chem. (2002) 277:33901–33905.
   PubMedGoogle Scholar
• HALDER SK, FINK M, WATERIVIAN MR, ROZMAN D: A cAMP-responsive element binding site is essential for sterol regulation of the human lanosterol 14a-demethylase gene (CYP51). Mol Endocrinol (2002) 16: 1853-1863.
   Google Scholar
• MISAWA K, HORIBA T, ARIMURA N et al.: Sterol regulatory element-binding protein-2 interacts with hepatocyte nuclear factor-4 to enhance sterol isomerase gene expression in hepatocytes. Biol. Chem. (2003) 278:36176–36182.
   Google Scholar
• OLINER JD, ANDRESEN JM, HANSEN SK, ZHOU S, TJIAN R: SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. Genes Dev. (1996) 10:2903–2911.
   PubMedGoogle Scholar
• ERICSSON J, EDWARDS PA: CBP is required for sterol-regulated and sterol regulatory element-binding protein-regulated transcription. Biol. Chem. (1998) 273:17865–17870.
   Google Scholar
• CARDINAUX JR, NOTIS JC, ZHANG Q et al.: Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation. MM. Cell. Biol. (2000) 20:1546–1552.
   Web of Science ®Google Scholar
• TAATJES DJ, NAAR AM, ANDEL F III, NO GALES E, TJIAN R: Structure, function, and activator-induced conformations of the CRSP coactivator. Science (2002) 295:1058–1062.
   PubMed Web of Science ®Google Scholar
• NAAR AM, TAATJES DJ, ZHAI W, NO GALES E, TJIAN R: Human CRSP interacts with RNA polymerase II CTD and adopts a specific CTD-bound conformation. Genes Dev. (2002) 16:1339–1344.
   PubMed Web of Science ®Google Scholar
• NAAR AM, BEAURANG PA, ZHOU S, ABRAHAM S, SOLOMON W, TJIAN R: Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature (1999) 398:828–832.
   PubMed Web of Science ®Google Scholar
• GIANDOMENICO V, SIMONSSON M, GRONROOS E, ERICSSON J: Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Ma Cell. Biol. (2003) 23:2587–2599.
   Google Scholar
• HORTON JD: Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem. Soc. Trans. (2002) 30:1091–1095.
   PubMed Web of Science ®Google Scholar
• LITTLEWOOD TD, EVAN GI: Transcription factors 2: helix-loop-helix. Protein Profile (1995) 2:621–702.
   PubMedGoogle Scholar
• ATHANIKAR JN, OSBORNE TF: Specificity in cholesterol regulation of gene expression by coevolution of sterol regulatory DNA element and its binding protein. Proc. Natl. Acad. Sci. USA (1998) 95:4935–4940.
   PubMedGoogle Scholar
• HORTON JD, BASHMAKOV Y, SHIMOMURA I, SHIMANO H: Regulation of sterol regulatory element binding proteins in livers of fasted and refeed mice. Proc. Natl. Acad. Sci. USA (1998) 95:5987–5992.
   PubMed Web of Science ®Google Scholar
• HORTON JD, SHIMOMURA I, BROWN MS, HAMMER RE, GOLDSTEIN JL, SHIMANO H: Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. Clin. Invert. (1998) 101:2331–2339.
   Google Scholar
• HORTON JD, SHIMANO H, HAMILTON RL, BROWN MS, GOLDSTEIN JL: Disruption of LDL receptor gene in transgenic SREBP-la mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL. Clin. Invest. (1999) 103:1067–1076.
   Google Scholar
• HORTON JD, SHIMOMURA I, IKEMOTO S, BASHMAKOV Y, HAMMER RE: Overexpression of SREBP-la in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. Biol. Chem. (2003) 278:36652–36660.
   Google Scholar
• KORN BS, SHIMOMURA I, BASHMAKOV Y et al.: Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N). Clin. Invest. (1998) 102:2050–2060.
   Google Scholar
• LIANG G, YANG J, HORTON JD, HAMMER RE, GOLDSTEIN JL, BROWN MS: Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. Biol. Chem. (2002) 277:9520–9528.
   Google Scholar
• MATSUDA M, KORN BS, HAMMER RE et al: SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. Genes Dev. (2001) 15:1206–1216.
   PubMed Web of Science ®Google Scholar
• •First proof in vivo that SCAP plays an essential role in the sterol-regulated cleavage process.
   Google Scholar
• SHIMANO H, HORTON JD, HAMMER RE, SHIMOMURA I, BROWN MS, GOLDSTEIN JL: Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-la. Gin. Invest. (1996) 98:1575–1584.
   PubMed Web of Science ®Google Scholar
• SHIMANO H, HORTON JD, SHIMOMURA I, HAMMER RE, BROWN MS, GOLDSTEIN JL: Isoform lc of sterol regulatory element binding protein is less active than isoform la in livers of transgenic mice and in cultured cells. j Clin. Invest. (1997) 99:846–854.
   PubMed Web of Science ®Google Scholar
• SHIMANO H, SHIMOMURA I, HAMMER RE et al.: Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. Gin. Invest. (1997) 100:2115–2124.
   PubMed Web of Science ®Google Scholar
• SHIMANO H, YAHAGI N, AMEMIYA-KUDO M et al.: Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J. Biol. Chem. (1999) 274:35832–35839.
   PubMed Web of Science ®Google Scholar
• SHIMOMURA I, HAMMER RE, RICHARDSON JA et al: Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-lc in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. (1998) 12:3182–3194.
   PubMed Web of Science ®Google Scholar
• ••Provides for the first time direct evidencethat alterations in the expression of SREBP1 can be associated with diabetes and dyslipidaemia, being essential features of the metabolic syndrome.
   Google Scholar
• SHIMOMURA I, HAMMER RE, IKEMOTO S, BROWN MS, GOLDSTEIN JL: Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature (1999) 401:73–76.
   PubMed Web of Science ®Google Scholar
• YAHAGI N, SHIMANO H, HASTY AH et al.: Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. Biol. Chem. (2002) 277:19353–19357.
   Google Scholar
• YANG J, GOLDSTEIN JL, HAMMER RE,MOON YA, BROWN MS, HORTON JD: Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene. Proc. Nati Acad. Sci USA (2001) 98:13607–13612.
   PubMedGoogle Scholar
• LAWRENCE RD: Lypodystrophy and hepatomegaly with diabetes, lipaemia and other metabolic disturbances. A case throwing new light on the action of insulin. Lancet (1946) 1:724–731.
   Google Scholar
• SEIP M, TRYGSTAD O: Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr. Stipp]. (1996) 413:2–28.
   PubMedGoogle Scholar
• ZHANG Y, YIN L, HELLGARTNER FB: SREBP-1 integrates the actions of thyroid hormone, insulin, cAMP, and medium-chain fatty acids on ACCa transcription in hepatocytes. J. Lipid Res. (2003) 44:356–368.
   PubMedGoogle Scholar
• SHECHTER I, DAI P, HUO L, GUAN G:IDH1 gene transcription is sterol regulated and activated by SEBP- la and SREBP-2 in human hepatoma HepG2 cells: evidence that IDH1 may regulate lipogenesis in hepatic cells. J. Lipid Res. (2003) 44:2169–2180.
   PubMedGoogle Scholar
• LATASA MJ, GRIFFIN MJ, MOON YS et al.: Occupancy and function of the -150 sterol regulatory element and -65 E-box in nutritional regulation of the fatty acid synthase gene in living animals. Ma Cell. Biol. (2003) 23:5896–5907.
   Google Scholar
• SHIN DJ, OSBORNE TF: Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2). J. Biol. Chem. (2003) 278:34114–34118.
   PubMed Web of Science ®Google Scholar
• OH SY, PARK SK, KIM JVV et al.: Acetyl-CoA carboxylase bet gene is regulated by sterol regulatory element-binding protein-1 in liver. J. Biol. Chem. (2003) 278:28410–28417.
   PubMed Web of Science ®Google Scholar
• YABE D, KOMURO R, LIANG G et al: Liver-specific mRNA for Insig-2 downregulated by insulin: implications for fatty acid synthesis. Proc. Natl. Acad. Sci. USA (2003) 100:3155–3160.
   PubMed Web of Science ®Google Scholar
• MUR C, ARRIBAS M, BENITO M, VALVERDE AM: Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation. Endocrinology (2003) 144:581–593.
   PubMed Web of Science ®Google Scholar
• SEKIYA M, YAHAGI N, MATSUZUAKA T et al: Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP- I suppression. Hepatology (2003) 38:1529–1539.
   PubMed Web of Science ®Google Scholar
• •This study shows direct evidence for the link between nutrients, for example, PUFA, SREBP1 and steatosis hepatitis.
   Google Scholar
• DOBBINS RL, SZCZEPANIAK LS, BENTLEY B, ESSER V, MYHILL J, MCGARRY JD: Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes (2001) 50:123–130.
   PubMed Web of Science ®Google Scholar
• JACOB S, MACHANN J, RETT K et al.: Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of Type 2 diabetic subjects. Diabetes (1999) 48:1113–1119.
   PubMed Web of Science ®Google Scholar
• MARCHESINI G, BRIZI M, BIANCHI G et al.: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 50:1844–1850.
   PubMed Web of Science ®Google Scholar
• UNGER RH, ZHOU YT: Lipotoxicity of I3-cells in obesity and in other causes of fatty acid spillover. Diabetes (2001) 50\(Suppl. 1):5118–5121.
   Google Scholar
• UNGER RH, ORCI L: Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. (2001) 15:312–321.
   PubMed Web of Science ®Google Scholar
• •Good review on lipotoxicity and its clinical implications.
   Google Scholar
• MINGRONE G, ROSA G, GRECO AV et al.: Intramyocytic lipid accumulation and SREBP- lc expression are related to insulin resistance and cardiovascular risk in morbid obesity. Atherosclerosis (2003) 170:155–161.
   PubMedGoogle Scholar
• MCGARRY JD: Dysregulation of fatty acid metabolism in the etiology of Type 2 diabetes. Diabetes (2002) 51:7–18.
   PubMed Web of Science ®Google Scholar
• •A detailed review on the experimental evidence coupling intracellular lipid content to features of insulin resistance.
   Google Scholar
• UNGER RH: Lipotcodc diseases. Anna. Rev. Med. (2002) 53:319–336.
   PubMed Web of Science ®Google Scholar
• KIM JK, GAVRILOVA O, CHEN Y, REITMAN ML, SHULMAN G: Mechanisms of insulin resistance in A-ZIP/17-1 fatless mice. J. Biol. Chem. (2000) 276:8456–8460.
   Google Scholar
• YAMAUCHI T, KAMON J, MINOKOSHI Y et al.: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. (2002) 8:1288–1295.
   PubMed Web of Science ®Google Scholar
• ORAL EA, SIMHA V, RUIZ E et al.: Leptin-replacement therapy for lipodystrophy. N Engl. J. Med. (2002) 346:570–578.
   PubMed Web of Science ®Google Scholar
• KELLEY DE, GOODPASTER BH: Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes (2001) 24:933–941.
   Google Scholar
• SONGS: The role of increased liver triglyceride content: a culprit of diabetic hyperglycaemia? Diabetes Metab. Res. Rev (2002) 18:5–12.
   Google Scholar
• NERURKAR PV, SHIKUMA CM, NERURKAR VR: Sterol regulatory element-binding proteins and reactive oxygen species: potential role in highly-active antiretroviral therapy (HAART)-associated lipodystrophy. Clin. Biocbein. (2001) 34:519–529.
   PubMedGoogle Scholar